Temasek-Backed Manipal Health Readies Billion-Dollar IPO, Targeting Massive Debt Reduction

Temasek-Backed Manipal Health Readies Billion-Dollar IPO, Targeting Massive Debt Reduction​

Temasek-backed Manipal Health Enterprises is preparing to launch a significant initial public offering (IPO), which promises to be one of the largest by an Indian healthcare services provider. The highly anticipated offering is slated for later this month, following the successful completion of a previous issue led by SBI Funds Management in mid-July.

The company is expected to announce the official price band on July 24th. Subsequently, the IPO is scheduled to be open for subscription from July 29 to July 31. This offering represents a major capitalization event for the healthcare giant.

Offer Structure and Investor Participation​

The IPO structure comprises two main components: a fresh issue of shares worth up to ₹8,000 crore, and an offer for sale (OFS) totaling up to 4.32 crore shares. The OFS component involves the existing investors and promoter entities selling their holdings.

Promoter entities participating in the OFS include Imperius Healthcare Investments and Manipal Education and Medical Group India. Existing major investors expected to sell shares are TPG SG Magazine, Seventy Second Investment Company, Novo Holdings Invest Asia, and Phoenix Bear Investments.

Strategic Use of Proceeds​

Manipal Health Enterprises has outlined a clear plan for deploying the funds raised from the fresh issue. The primary focus is on substantial debt reduction within the organization.

Approximately ₹5,378 crore has been earmarked specifically to repay or prepay borrowings at its subsidiary, Manipal Hospitals. Additionally, around ₹574 crore will be utilized for acquiring a minority stake in Sahyadri Hospitals, which serves as the step-down arm of the group.

Market Context and Book Running Managers​

This upcoming IPO marks the second billion-dollar listing event for the company this year. Previously, SBI Funds raised ₹9,813 crore through an IPO completed earlier in 2026, which was reported as the largest such issue so far and achieved a subscription rate of 41.66 times.

A consortium of leading financial institutions has been appointed as book-running lead managers for the Manipal issue. These firms include Kotak Mahindra Capital, Axis Capital, DBS Bank India, Goldman Sachs India Securities, Jefferies India, JP Morgan India, and UBS Securities India.